ACT, VPSCRO to conduct clinical trials in India, China

Hyderabad, Apr 8 (UNI) Suven Life Sciences Limited today announced that its clinical research division Asian Clinical Trials (ACT) has entered into strategic alliance with VPSCRO, a Clinical Research Organisation (CRO) based in Beijing, China, to conduct trial services in India and China.

In a release here, Suven Life Sciences CEO Venkat Jasti said the strategic alliance would allow both the companies to offer a comprehensive range of clinical services to global sponsors with the state of the art infrastructure, network of trained investigation in India and China by leveraging their expertise for the conduct of quality clinical research.

VPSCRO Global Business Development Director Charlie Xu said ''together we will build a world class CRO platform to conduct clinical trials in Asia region.'' ''We are very enthusiastic with the many opportunities to make this alliance a success not only for ACT and VPSCRO, but also to our global sponsors around the world,'' Mr Jasti said in the release.

UNI AP VA DS 1706